Received First Site Institutional Review Board (IRB) Approval to Proceed With the Phase 1 Trial of DA-1726 in Obesity Phase 1 Trial of DA-1726 Expected to Dose.
/PRNewswire/ Endo International plc (OTC: ENDPQ) announced today that five new presentations related to Peyronie s disease, or PD, and XIAFLEX® (collagenase.
Endo International plc: Endo Announces Five Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
DA-1726 Phase 1 IND Filing Expected by Year End 2023
Board Strengthened with Recent Appointment of Industry Veteran, James P. Tursi, M.D.
Cash and Cash Equivalents of $25.8 Million, Expected to Fund.
NeuroBo Pharmaceuticals (NRBO) Appoints James P. Tursi to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.